Evidence map›Paper›PMID 37293474›Full record

ArticleRSC advances2023

Synthesis and characterisation of novel composite sunscreens containing both avobenzone and octocrylene motifs.

Adam M Cowden, Abigail L Whittock, Emily L Holt, Vasilios G Stavros, Martin Wills

Open access · goldAbstract read
In one paragraph

Article in RSC advances, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
4.8field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Photokinetics of Mixtures of Independent Photoreactions.Molecules (Basel, Switzerland) · 2025
    Article
  3. Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Adam M CowdenDepartment of Chemistry, University of Warwick Coventry CV4 7AL UK m.wills@warwick.ac.uk.ORCID https://orcid.org/0000-0003-2695-6345
Abigail L WhittockDepartment of Chemistry, University of Warwick Coventry CV4 7AL UK m.wills@warwick.ac.uk.ORCID https://orcid.org/0000-0001-6361-3291
Emily L HoltDepartment of Chemistry, University of Warwick Coventry CV4 7AL UK m.wills@warwick.ac.uk.ORCID https://orcid.org/0000-0001-7035-2878
Vasilios G StavrosDepartment of Chemistry, University of Warwick Coventry CV4 7AL UK m.wills@warwick.ac.uk.ORCID https://orcid.org/0000-0002-6828-958X
Martin WillsDepartment of Chemistry, University of Warwick Coventry CV4 7AL UK m.wills@warwick.ac.uk.ORCID https://orcid.org/0000-0002-1646-2379
University of Warwick · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Avobenzone and octocrylene are popular sunscreen active ingredients. Experiments that probe the stability of avobenzone in binary mixtures with octocrylene are presented, together with the synthesis of a class of novel composite sunscreens that were designed by covalently linking avobenzone and octocrylene groups. Spectroscopy, both steady-state and time-resolved, of the fused molecules was performed to investigate the stability of the new molecules and their potential function as ultraviolet filters. Computational results are detailed for truncated versions of a subset of the molecules to reveal the energy states underlying the absorption processes of this new class of sunscreen. The results indicate that the combination of elements of the two sunscreen molecules into one molecule creates a derivative with good stability to UV light in ethanol and in which the main degradation pathway of the avobenzone component in acetonitrile is reduced. Derivatives containing

Identifiers

PMID37293474
PMCPMC10245224
OpenAlexW4379801455

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.